Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.
Dimopoulos, M A
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2014 - 195-200 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdt483 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Boronic Acids--administration & dosage
Bortezomib
Female
Glomerular Filtration Rate
Humans
Kaplan-Meier Estimate
Male
Multiple Myeloma--complications
Multivariate Analysis
Proportional Hazards Models
Pyrazines--administration & dosage
Renal Insufficiency--etiology
Risk
Thalidomide--administration & dosage
Treatment Outcome
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2014 - 195-200 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdt483 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Boronic Acids--administration & dosage
Bortezomib
Female
Glomerular Filtration Rate
Humans
Kaplan-Meier Estimate
Male
Multiple Myeloma--complications
Multivariate Analysis
Proportional Hazards Models
Pyrazines--administration & dosage
Renal Insufficiency--etiology
Risk
Thalidomide--administration & dosage
Treatment Outcome